These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1114 related articles for article (PubMed ID: 1643424)

  • 41. Antibody-dependent cellular cytotoxicity mediated by murine lymphocytes activated in recombinant interleukin 2.
    Shiloni E; Eisenthal A; Sachs D; Rosenberg SA
    J Immunol; 1987 Mar; 138(6):1992-8. PubMed ID: 3493293
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pre-clinical models for immunotherapy of melanoma.
    Reisfeld RA
    Prog Clin Biol Res; 1989; 288():183-93. PubMed ID: 2654950
    [No Abstract]   [Full Text] [Related]  

  • 43. Induction of antitumor immunity and treatment of preestablished tumor by interleukin-6-gene-transfected melanoma cells combined with low-dose interleukin-2.
    Cao X; Zhang W; Gu S; Yu Y; Tao Q; Ye T
    J Cancer Res Clin Oncol; 1995; 121(12):721-8. PubMed ID: 7499443
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protective immunization against melanoma by gp100 DNA-HVJ-liposome vaccine.
    Zhou WZ; Kaneda Y; Huang S; Morishita R; Hoon D
    Gene Ther; 1999 Oct; 6(10):1768-73. PubMed ID: 10516727
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genetic immunization of mice with human tyrosinase-related protein 2: implications for the immunotherapy of melanoma.
    Steitz J; Brück J; Steinbrink K; Enk A; Knop J; Tüting T
    Int J Cancer; 2000 Apr; 86(1):89-94. PubMed ID: 10728600
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synergistic effect of interleukin-2 and a vaccine of irradiated melanoma cells transfected to secrete staphylococcal enterotoxin A.
    Schrayer DP; Kouttab N; Hearing VJ; Wanebo HJ
    Clin Exp Metastasis; 2002; 19(1):43-53. PubMed ID: 11918082
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Induction of antitumor immunity with dendritic cells transduced with adenovirus vector-encoding endogenous tumor-associated antigens.
    Kaplan JM; Yu Q; Piraino ST; Pennington SE; Shankara S; Woodworth LA; Roberts BL
    J Immunol; 1999 Jul; 163(2):699-707. PubMed ID: 10395660
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Subcutaneous vaccination with irradiated, cytokine-producing tumor cells stimulates CD8+ cell-mediated immunity against tumors located in the "immunologically privileged" central nervous system.
    Sampson JH; Archer GE; Ashley DM; Fuchs HE; Hale LP; Dranoff G; Bigner DD
    Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10399-404. PubMed ID: 8816812
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adenovirus-mediated expression of melanoma antigen gp75 as immunotherapy for metastatic melanoma.
    Hirschowitz EA; Leonard S; Song W; Ferris B; Leopold PL; Lewis JJ; Bowne WB; Wang S; Houghton AN; Crystal RG
    Gene Ther; 1998 Jul; 5(7):975-83. PubMed ID: 9813669
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Further studies of the therapeutic effects of murine melanoma-specific monoclonal antibodies.
    Law LW; Vieira WD; Hearing VJ; Gersten DM
    Biochim Biophys Acta; 1994 Apr; 1226(1):105-9. PubMed ID: 7908833
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The mechanism of anti-tumor immune response against mouse melanoma to xenogeneic vaccination].
    Luo F; Mao YQ; Kan B; He QM; Jiang Y; Peng F; Yang L; Tian L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):757-60. PubMed ID: 15573746
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Production of monoclonal antibodies against the B700 murine melanoma antigen and their antimetastatic properties.
    Gersten DM; Moody D; Vieira WD; Law LW; Hearing VJ
    Biochim Biophys Acta; 1992 Feb; 1138(2):109-14. PubMed ID: 1540656
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Melanoma and immunity.
    Rheins LA; Nordlund JJ
    Immunol Ser; 1989; 46():769-87. PubMed ID: 2484957
    [No Abstract]   [Full Text] [Related]  

  • 54. Characterization of a novel human tumor antigen interleukin-13 receptor alpha2 chain.
    Kawakami K; Terabe M; Kawakami M; Berzofsky JA; Puri RK
    Cancer Res; 2006 Apr; 66(8):4434-42. PubMed ID: 16618770
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Photosensitizer and Light Pave the Way for Cytosolic Targeting and Generation of Cytosolic CD8 T Cells Using PLGA Vaccine Particles.
    Bruno C; Waeckerle-Men Y; Håkerud M; Kündig TM; Gander B; Johansen P
    J Immunol; 2015 Jul; 195(1):166-73. PubMed ID: 26019274
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunosuppressive effects of interleukin-12 coexpression in melanoma antigen gene-modified dendritic cell vaccines.
    Ribas A; Amarnani SN; Buga GM; Butterfield LH; Dissette VB; McBride WH; Glaspy JA; Ignarro LJ; Economou JS
    Cancer Gene Ther; 2002 Nov; 9(11):875-83. PubMed ID: 12386826
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interleukin-2-secreting mouse fibroblasts transfected with genomic DNA from murine melanoma cells prolong the survival of mice with melanoma.
    Kim TS; Cohen EP
    Cancer Res; 1994 May; 54(10):2531-5. PubMed ID: 8168073
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intracerebral versus subcutaneous immunization with allogeneic fibroblasts genetically engineered to secrete interleukin-2 in the treatment of central nervous system glioma and melanoma.
    Glick RP; Lichtor T; Mogharbel A; Taylor CA; Cohen EP
    Neurosurgery; 1997 Oct; 41(4):898-906; discussion 906-7. PubMed ID: 9316052
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of cell wall skeleton and monophosphoryl lipid A adjuvant on the immunogenicity of a murine B16 melanoma vaccine.
    Johnston D; Bystryn JC
    J Natl Cancer Inst; 1991 Sep; 83(17):1240-5. PubMed ID: 1870150
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Natural killer cells play a critical role in the immune response following immunization with melanoma-antigen-engineered dendritic cells.
    Wargo JA; Schumacher LY; Comin-Anduix B; Dissette VB; Glaspy JA; McBride WH; Butterfield LH; Economou JS; Ribas A
    Cancer Gene Ther; 2005 Jun; 12(6):516-27. PubMed ID: 15775996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 56.